InvestorsHub Logo
Followers 54
Posts 4775
Boards Moderated 0
Alias Born 12/08/2011

Re: ThomasAn post# 72887

Tuesday, 06/19/2012 11:07:54 AM

Tuesday, June 19, 2012 11:07:54 AM

Post# of 129054
Well all they can do until they get through the FDA is sell shares. I am fine with the dilution and all the PR's.

Says right in the 10-k they need to dilute to keep operations going.

Since they are one of the only outfits trying to get cannabis oil mainstream I support them. Everything is set for them to fail. Only investors can support them right now.

I listened to the CEO speak at the conference, and the stuff going on here is just way above most peoples comprehension.

The major fallacy of modern medicine is that health is the absence for sickness. Common sense tells us there is something as better health. This CEO gave such a good explanation of what life is, he can put a good definition on health.

This is a paradigm shift in medicine. Anyways, they have a product out now and small but real revenues. As more and more states legalize, they will get more and more investor interest and begin to expand.

Seriously, you will take your money out of here to go invest in some other momo stocks?

CBIS is spreading the message that cannabis cure cancer. Even if they fail, I want to fund the spreading of that message.

If this turned out to be a P&D i wouldn't care, people still learned the truth. But considering their message, and the credentials of the CEO he wants this to be big.

Melamede is one of the leading Cannabinoid researchers. He is literally at the forefront of Cannabis Science. Would he want to ruin all that for money? When he has the change to make billions and change the world?

PR's are all they had for a long time, but everything is coming together now.

Now is the real test, who are the believers, they will be rewarded.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.